Thesis

Thesis

Personalized nootropic supplements for cognitive enhancement

About Thesis

Simplify's Rating
Why Thesis is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Consumer Goods

Company Size

51-200

Company Stage

Series A

Total Funding

$13.6M

Headquarters

New York City, New York

Founded

2017

Overview

Thesis specializes in creating personalized nootropic supplements aimed at enhancing cognitive functions like memory, creativity, and motivation. Their products work by offering custom-tailored blends based on individual goals and lifestyles, which users select after completing an online quiz. This quiz helps Thesis recommend a starter kit containing four different nootropic blends for customers to sample over a month. To further refine their experience, users can consult with wellness coaches and nootropic experts. What sets Thesis apart from competitors is its focus on personalization and the use of high-quality, rigorously tested ingredients sourced from the USA, including functional mushrooms and choline sources. The goal of Thesis is to optimize brain performance for health-conscious individuals, including students, professionals, and athletes, by providing effective cognitive enhancement solutions.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in personalized health solutions boosts demand for Thesis's products.
  • The global nootropics market is projected to grow at a 12.5% CAGR until 2030.
  • Subscription-based models in health and wellness are seeing increased consumer adoption.

What critics are saying

  • Increased competition from established brands could dilute Thesis's market share.
  • Potential regulatory scrutiny may lead to higher operational costs for Thesis.
  • Supply chain disruptions could affect the availability of key ingredients for Thesis.

What makes Thesis unique

  • Thesis offers personalized nootropic supplements tailored to individual brain chemistry.
  • The company uses high-quality, USA-sourced ingredients like functional mushrooms and choline.
  • Thesis provides wellness coaching to optimize cognitive enhancement for each customer.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$13.6M

Below

Industry Average

Funded Over

2 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Below Average

Industry standards

$15M
$8.2M
Discord
$8.4M
Thesis
$15M
Canva
$30M
Kalshi

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Unlimited Paid Time Off

Hybrid Work Options

Wellness Program

Company Equity

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 1%

2 year growth

↑ 5%
Crypto Daily
Apr 10th, 2024
Bitcoin Layer-2 Platform Mezo Launches With $21M Series A Funding

The announcement was made after Thesis secured a $21 million Series A funding led by Pantera.

Business Wire
May 4th, 2023
Thesis, the First High Quality and Customized Nootropics Solution, Raises Total of $13.5 Million in Funding

Thesis, the company that offers a customized approach to cognitive performance products based on your unique brain chemistry, today announced that it

Axios
May 2nd, 2023
Supplements brand Thesis raises over $13M

Unilever Ventures is a major investor as the startup invests in executive hires and clinical trials.

Recently Posted Jobs

Sign up to get curated job recommendations

Thesis is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →